Company news

Sword launches Pulse, an always-on AI cardiometabolic solution

Sword Health Innovation Team

Footnotes

1

National Association of Community Health Centers, 2024

2

AMN Healthcare 2025 Survey

3

Peterson-KFF Health System Tracker

4

Karakasis P, et al. Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis. Metabolism. 2025 Mar;164:156113. doi: 10.1016/j.metabol.2024.156113. Epub 2024 Dec 22. PMID: 39719170. Liu Z, et al. Incretin Receptor Agonism, Fat-free Mass, and Cardiorespiratory Fitness: A Narrative Review. J Clin Endocrinol Metab. 2025 Sep 16;110(10):2709-2717. doi: 10.1210/clinem/dgaf335. PMID: 40488294; PMCID: PMC12448640.

5

(Kasher Meron M, et al. GLP-1 receptor agonists and the risk of fragility fractures in older adults with type 2 diabetes. J Clin Endocrinol Metab. 2026 Feb 10:dgag056. doi: 10.1210/clinem/dgag056. Epub ahead of print. PMID: 41665888)

Portugal 2020Norte 2020European UnionPlano de Recuperação e ResiliênciaRepública PortuguesaNext Generation EU